Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2019 Jan 7;129(2):496–498. doi: 10.1172/JCI125958

The L-type calcium channel current modulation mechanism: the plot thickens and fogs

Brooke M Ahern 1, Jonathan Satin 1,
PMCID: PMC6355207  PMID: 30614816

Abstract

Stressful situations provoke the fight-or-flight response, incurring rapid elevation of cardiac output via activation of protein kinase A (PKA). In this issue of the JCI, Yang et al. focus on the L-type calcium channel complex (LTCC), and their findings require reexamination of dogmatic principles. LTCC phosphorylation sites identified and studied to date are dispensable for PKA modulation of LTCC; however, a CaVβ2-CaV1.2 calcium channel interaction is now shown to be required. Yang et al. suggest a new hypothesis that LTCC modulation involves rearrangement of auxiliary proteins within the LTCC. However, we still do not know the targets of PKA that mediate LTCC modulation.

CaVβ2: a critical auxiliary protein in the heart

The acute stress response, colloquially referred to as the fight-or-flight response, initiates with a burst of sympathetic nervous system (SNS) activity resulting in elevated catecholaminergic signaling. β-adrenergic receptors (β-ARs) on cardiomyocytes transmit SNS activity into elevated cardiac output. The L-type calcium channel complex (LTCC) is an initial proximal effector of β-AR activation in the myocardium. Catecholaminergic activation of β-ARs results in increased Ca2+ current through the LTCC (ICa,L) with channel activation occurring at lower membrane voltage. The net effect is increased ICa,L, resulting in accentuated excitation-contraction coupling in the ventricle and faster spontaneous depolarization in the sinoatrial node, thus contributing to increased contraction and faster heart rate, respectively. This increased ICa,L by β-AR signaling is commonly called modulation. Despite the central physiological importance of CaV1.2 modulation combined with extensive investigations to uncover molecular mechanisms of action, we still don’t know how the LTCC is modulated.

The LTCC is a heteromultimeric protein complex. In the myocardium, CaV1.2 is the major pore-forming subunit. In older literature, this has been called the α-subunit. An additional array of proteins directly and/or indirectly complex with CaV1.2 (1). CaVβ, specifically CaVβ2 in the heart, is a critical auxiliary protein (2). For heterologous expression systems, coexpression of α- and β-subunits is necessary and sufficient to recapitulate a near-native ICa,L; however, it has not been possible to reproduce CaV1.2 modulation in heterologous systems (3). One interpretation is that key accessory proteins required for modulation are not present in heterologous expression systems. Regardless, the ability of CaVβ to increase CaV1.2 trafficking in heterologous expression systems, and to modify CaV1.2 gating underscores the central contribution of CaVα-CaVβ interactions for LTCC function (4). The linker between repeat segments I and II on CaV1.2 contains a so-called α-interaction domain (AID) that confers a biochemically stable complex between CaV1.2 and CaVβ2. Thus, first principles suggest that the α-β subunit interaction predominates interactions among a sea of multiple proteins that comprise the LTCC complex.

Decades of study unequivocally support active protein kinase A (PKA) as the link from β-AR activation to CaV1.2 modulation (5). PKA is a kinase, thus spurring the search for substrate sites within the LTCC that might be critical to transduce CaV1.2 modulation. In this edition of the JCI, Yang et al. continue to exploit a clever experimental system to reveal more of what we still don’t know about CaV1.2 modulation (6). They introduce a transgene in mice to overexpress a CaV1.2 construct containing a dihydropyridine-insensitive mutation. This so-called pseudo-WT (pWT) channel is transcriptionally activated from a tetracycline-inducible promoter to allow limited temporal overexpression of CaV1.2 in the myocardium. The use of nisoldipine then allows dissection of transgene driven from endogenous ICa,L. As long as there are no rapid remodeling events in the heart, then outcomes can be interpreted as occurring in healthy ventricular cardiomyocytes. By adding mutations onto the CaV1.2-AID, the authors were able to interrogate adult ventricular cardiomyocyte ICa,L carried by mutant CaV1.2. The outcomes using this transgenic strategy are unexpected and quite frankly, surprising.

Are all known PKA substrate phosphor-serine residues dispensable for modulation?

Apparently, the brief answer to the above posed question is simply, yes. Studies of single established CaV1.2 PKA-mediated phosphorylation sites eliminated the requirement for CaV1.2 sites Ser1928 (7), Ser1700, and Thr1704 (8) as well as CaVβ sites Ser459, Ser478, and Ser479 (9). The present work and most recent past publications from the Marx group eliminate many (if not all) of the prospective phosphorylation sites on CaV1.2 in unison, yet modulation still occurs (8, 10). Their latest work using CaV1.2-AID mutations to prevent α-β interaction convincingly demonstrates a requirement for α-β interaction to confer ICa,L modulation. This suggests that modulation via key protein-protein interactions, rather than one or more phosphoregulatory sites on CaV1.2 or CaVβ2 are involved (Figure 1). If no known phosphorylation events are identifiable as mechanisms of modulation, then which protein interactions confer a modulated ICa,L? Moreover, why are CaV1.2-Ser1928 and -Ser1701 conserved and phosphorylated by PKA? It is hard to understand what selection pressure exists to conserve the utilization of these sites across species. One speculative explanation might hold that nonmyocardial ICa,L modulation has differential mechanisms of modulation. For example, Ser1928 is essential for β2-AR signaling in neurons (11) and vascular smooth muscle (12). Application of Yang et al.’s transgene system in noncardiomyocytes would be an interesting test of the hypothesis that CaV1.2 phosphor-serine site conservation is attributable to essential nonmyocardial modulation mechanisms. Then the implication is that the LTCC heteromultimeric complex constituents differ across tissues.

Figure 1. CaVβ2-CaV1.2 interaction is not required for forward trafficking, but is required for CaV1.2 modulation by PKA.

Figure 1

(A) Old dogma: CaVβ-CaVα interaction on the Golgi apparatus promotes forward trafficking. CaV1.2 in the transverse tubules is modulated by one or more phosphoregulatory sites on CaV1.2 and/or CaVβ2. (B) New paradigm: CaVβ-CaVα interaction is not required for forward trafficking, and in the transverse tubules CaV1.2 modulation requires CaVβ, and perhaps additional accessory subunits.

CaVβ: dispensable for trafficking?

CaV1.2 forward trafficking dogma holds that Cavβ promotes localizing CaV1.2 to surface membrane (4). Early studies based on heterologous systems demonstrated that the β subunit acts as a chaperone for CaV1.2 to exit the Golgi complex and stabilizes channel complexes once in the membrane (1315). More recent work, also in heterologous expression systems, attributes forward trafficking function to α-β interaction (16). By contrast in this issue of the JCI, Yang et al. show that subcellular localization of CaV1.2 was unaffected and peak Ca2+ currents increased when ICa,L was measured from LTCC with CaV1.2–AID-mutant channels (6). In other words, the assumption is that forward trafficking was unaffected under conditions whereby α-β interaction could not occur. A reasonable interpretation is that α-β is dispensable for forward trafficking in cardiomyocytes (Figure 1). There are, however, some idiosyncrasies in this innovative approach. For example, pseudo-WT and AID-mutant CaV1.2 cardiomyocytes display a smaller percentage of contraction compared with that of nontransgenic cardiomyocytes, even though pWT and AID have increased Ca2+ currents. It is clear that CaV1.2 AID mutants can trigger excitation-contraction coupling, but the quantitative mismatch is a puzzling issue worthy of speculation. Recent studies showed that the location of L-type calcium channels within the cardiomyocyte could determine how calcium is used by the cell. Channel complexes in transverse tubules may be the source of contractile Ca2+, whereas channel complexes in caveolin-3 contribute to signaling Ca2+ (17). In cells from failing hearts, channel complexes dislocate to the sarcolemma surface, which could promote arrhythmias and contribute to the pathophysiology of heart failure (18). In this vein, it would be interesting to determine whether CaVβ is dispensable for compartment-specific trafficking such as might be altered during pathological remodeling.

Conclusions

Assuming that the transgenic system employed by Yang et al. recapitulates native LTCC complexes with high fidelity leads us to two broad conclusions that require reevaluation of mechanisms of modulation and LTCC cell biology. First, the necessity of an α-β interaction for ICa,L modulation without an identifiable PKA substrate site suggests the novel idea that signal transduction from PKA activation to ICa,L modulation requires key protein-protein interactions. This does not obviate the earlier pervasive notion that CaV1.2 (or CaVβ2) phosphorylation triggers allosteric effects resulting in modulation; rather, this work highlights the importance of consideration of LTCC protein-protein interactions, which can plausibly extend beyond α-β subunit interactions. However, we still don’t know the relevant mechanism for modulation. The second conclusion from this study highlights the perils of relying on reductionist heterologous expression systems to recapitulate the cell biology of native heteromultimeric complexes such as the LTCC. Indeed, heterologous expression systems fail to recapitulate modulation, and this new study suggests that earlier trafficking studies require cautious interpretation because of the discordant finding that CaVβ promotes forward trafficking in reduced systems but is not necessary in cardiomyocytes. The one issue to temper enthusiasm for the Yang et al. transgenic system is that there is stoichiometric overexpression of the α-subunit. It is a metaphorical application of the Heisenberg uncertainty principle loosely extended to the biological realm. In this case, to study native LTCC we need to overexpress a single subunit, thus potentially changing the balance of proteins in the LTCC heteromultimeric complex.

In summary, the work of Yang et al. eliminated the usual suspects of phosphorylation sites required for ICa,L modulation, and raised the specter of a mechanism involving multiple protein interactions with the LTCC complex; however, which proteins might be essential beyond α-β interaction, along with relevant PKA substrates for ICa,L modulation, remain foggy.

Acknowledgments

This work is supported by NIH grant HL131782 and grant T32 GM118292 (to BMA).

Version 1. 01/07/2019

Electronic publication

Version 2. 02/01/2019

Print issue publication

Footnotes

Conflict of interest: The authors have declared that no conflict of interest exists.

Reference information: J Clin Invest. 2019;129(2):496–498. https://doi.org/10.1172/JCI125958.

References

  • 1. Satin J. Regulation of cardiac calcium channels. In: Zipes DP, Jalife J, Stevenson WG, eds. Cardiac Electrophysiology: From Cell to Bedside. 7th ed. Philadelphia, Pennsylania, USA: Elsevier; 2017:96–105. [Google Scholar]
  • 2.Foell JD, et al. Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization. Physiol Genomics. 2004;17(2):183–200. doi: 10.1152/physiolgenomics.00207.2003. [DOI] [PubMed] [Google Scholar]
  • 3.Wei SK, et al. Ca2+ channel modulation by recombinant auxiliary β subunits expressed in young adult heart cells. Circ Res. 2000;86(2):175–184. doi: 10.1161/01.RES.86.2.175. [DOI] [PubMed] [Google Scholar]
  • 4.Gerster U, Neuhuber B, Groschner K, Striessnig J, Flucher BE. Current modulation and membrane targeting of the calcium channel α1C subunit are independent functions of the β subunit. J Physiol (Lond) 1999;517(Pt 2):353–368. doi: 10.1111/j.1469-7793.1999.0353t.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kamp TJ, Hell JW. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res. 2000;87(12):1095–1102. doi: 10.1161/01.RES.87.12.1095. [DOI] [PubMed] [Google Scholar]
  • 6.Yang L, et al. Cardiac CaV1.2 channels require β subunits for β-adrenergic–mediated modulation but not trafficking. J Clin Invest. 2019;129(2):647–658. doi: 10.1172/JCI123878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ganesan AN, Maack C, Johns DC, Sidor A, O’Rourke B. Beta-adrenergic stimulation of L-type Ca2+ channels in cardiac myocytes requires the distal carboxyl terminus of alpha1C but not serine 1928. Circ Res. 2006;98(2):e11–e18. doi: 10.1161/01.RES.0000202692.23001.e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yang L, Katchman A, Samad T, Morrow J, Weinberg R, Marx SO. β-Adrenergic regulation of the L-type Ca2+ channel does not require phosphorylation of α1C Ser1700. Circ Res. 2013;113(7):871–880. doi: 10.1161/CIRCRESAHA.113.301926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Brandmayr J, et al. Deletion of the C-terminal phosphorylation sites in the cardiac β-subunit does not affect the basic β-adrenergic response of the heart and the Ca(v)1.2 channel. J Biol Chem. 2012;287(27):22584–22592. doi: 10.1074/jbc.M112.366484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Katchman A, et al. Proteolytic cleavage and PKA phosphorylation of α1C subunit are not required for adrenergic regulation of CaV1.2 in the heart. Proc Natl Acad Sci U S A. 2017;114(34):9194–9199. doi: 10.1073/pnas.1706054114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Qian H, et al. Phosphorylation of Ser1928 mediates the enhanced activity of the L-type Ca2+ channel Cav1.2 by the β2-adrenergic receptor in neurons. Sci Signal. 2017;10(463):eaaf9659. doi: 10.1126/scisignal.aaf9659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nystoriak MA, et al. Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel Cav1.2 and vasoconstriction during acute hyperglycemia and diabetes. Sci Signal. 2017;10(463):eaaf9647. doi: 10.1126/scisignal.aaf9647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chien AJ, et al. Roles of a membrane-localized β subunit in the formation and targeting of functional L-type Ca2+ channels. J Biol Chem. 1995;270(50):30036–30044. doi: 10.1074/jbc.270.50.30036. [DOI] [PubMed] [Google Scholar]
  • 14.Brice NL, et al. Importance of the different β subunits in the membrane expression of the α1A and α2 calcium channel subunits: studies using a depolarization-sensitive α1A antibody. Eur J Neurosci. 1997;9(4):749–759. doi: 10.1111/j.1460-9568.1997.tb01423.x. [DOI] [PubMed] [Google Scholar]
  • 15.Yamaguchi H, Hara M, Strobeck M, Fukasawa K, Schwartz A, Varadi G. Multiple modulation pathways of calcium channel activity by a β subunit. Direct evidence of β subunit participation in membrane trafficking of the α1C subunit. J Biol Chem. 1998;273(30):19348–19356. doi: 10.1074/jbc.273.30.19348. [DOI] [PubMed] [Google Scholar]
  • 16.Rusconi F, et al. Peptidomimetic targeting of Cavβ2 overcomes dysregulation of the L-type calcium channel density and recovers cardiac function. Circulation. 2016;134(7):534–546. doi: 10.1161/CIRCULATIONAHA.116.021347. [DOI] [PubMed] [Google Scholar]
  • 17.Makarewich CA, et al. A caveolae-targeted L-type Ca2+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility. Circ Res. 2012;110(5):669–674. doi: 10.1161/CIRCRESAHA.111.264028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sanchez-Alonso JL, et al. Microdomain-specific modulation of L-type calcium channels leads to triggered ventricular arrhythmia in heart failure. Circ Res. 2016;119(8):944–955. doi: 10.1161/CIRCRESAHA.116.308698. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES